Home
News
Screeners
Insights
Adline Chem Lab
15.
79
0.00
(0.00%)
Market Cap
₹9.20 Cr
PE Ratio
-49.34
Industry
Healthcare
Buy
Sell
Company Performance:
1D
0.00%
1M
+25.32%
6M
+46.88%
1Y
0.00%
5Y
+102.96%
View Company Insights
Latest news about Adline Chem Lab
Adline Chem Lab cites small company exemption for RPT disclosure
39 mins ago
Today
Adline Chem Lab Limited invoked small company exemption under SEBI LODR Regulations, 2015. Paid-up equity share capital stood at ₹5.85 crore, below the ₹10 crore threshold. Net worth was negative ₹1.77 crore, falling within the ₹25 crore limit for exemption. Disclosure of Related Party Transactions under Regulation 23(9) deemed not applicable for H1FY27.
Adline Chem Lab holds 38th AGM, outlines shift to renewable energy
Sep 28, 2026
Adline Chem Lab sets September 28 AGM for auditor appointment, director regularization
Sep 04, 2026
Adline Chem Lab appoints V. V. Patel & Co as statutory auditor
Sep 01, 2026
Adline Chem Lab schedules Aug 27 board meeting to approve AGM notice
Aug 24, 2026
More news about Adline Chem Lab
14
Aug 26
Adline Chem Lab Q1 Results: Net profit turns positive to ₹4.01 lakh
Adline Chem Lab Ltd returned to profit in Q1FY27 with a net income of ₹4.01 lakh, reversing a prior-year loss. Revenue reached ₹11.99 lakh against nil in Q1FY26. However, the company faced a ₹1.06 lakh BSE penalty for non-appointment of a Company Secretary, highlighting ongoing governance challenges amidst improved operational metrics.
12
Jun 26
Adline Chem Lab accepts resignations of two independent directors
Adline Chem Lab Ltd accepted the resignations of Independent Directors Mr. Him Vyas and Mr. Krish Patel, effective June 12, 2026, due to personal and professional commitments. The company confirmed there are no other material reasons for the resignations.
11
Feb 26
Adline Chem Lab Reports Q3FY26 Loss of ₹6.46 Lakhs, Appoints New Chairman & MD
Adline Chem Lab Limited announced Q3FY26 financial results showing a net loss of ₹6.46 lakhs, improved from ₹12.26 lakhs loss in Q3FY25, with zero revenue from operations. The company also appointed Mr. Vrushank Balkrushna Patel as Chairman and Managing Director for five years, subject to shareholder approval.
30
Dec 25
Adline Chem Lab Updates CFO Resignation Details Following Board Changes
Adline Chem Lab Limited has submitted supplementary information regarding CFO Kuldip Ashokkumar Parekh's resignation due to better career opportunities, effective June 13, 2025. This follows the company's recent board restructuring in November 2025, where Vrushank Patel was appointed as Chairman replacing Sarang Bharatbhai Pathak. The company reported a loss before tax of ₹13.89 lakhs for the half-year ended September 30, 2025.
Adline Chem Lab
15.
79
0.0
(0.0%)
1 Year Returns:
0.00%
Industry Peers
Sun Pharmaceutical
1,743.00
(-
0.
90
%)
Divis Laboratories
9,087.00
(-
0.
63
%)
Torrent Pharmaceuticals
4,558.70
(+
0.
00
%)
Laurus Labs
2,069.00
(+
0.
43
%)
Zydus Life Science
1,113.90
(-
0.
81
%)
Cipla
1,324.10
(-
0.
08
%)
Dr Reddys Laboratories
1,242.50
(+
0.
77
%)
Aurobindo Pharma
1,621.40
(-
2.
73
%)
Mankind Pharma
2,253.20
(-
0.
98
%)
Lupin
1,939.20
(-
1.
14
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar